Analysed ONEMEDNET CORP (ONMD:NASDAQ) News Sources
OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data
06-04-2026
yahoo.com
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI
01-04-2026
yahoo.com
OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights
18-03-2026
yahoo.com
OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry
27-02-2026
yahoo.com
OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale, Accelerating Recurring Revenue from Life Sciences and AI Customers
26-02-2026
yahoo.com
OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers
24-02-2026
yahoo.com
OneMedNet Reports Record 2025 Bookings of $2.79 Million, Surpassing Prior Year by More Than 4.1X and Accelerating Subscription Transition
12-02-2026
yahoo.com
What is the current price of ONEMEDNET CORP (ONMD:NASDAQ)?
The current price of ONEMEDNET CORP (ONMD:NASDAQ) is $0.8835.
ONEMEDNET CORP (ONMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of ONEMEDNET CORP (ONMD:NASDAQ) since the previous trading day is $0.0057.
ONEMEDNET CORP (ONMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of ONEMEDNET CORP (ONMD:NASDAQ) since the previous trading day is 0.6494%.
What is the most recent average sentiment score for ONEMEDNET CORP (ONMD:NASDAQ)?
The most recent average sentiment score for ONEMEDNET CORP (ONMD:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for ONEMEDNET CORP (ONMD:NASDAQ)?
The most recent sentiment for ONEMEDNET CORP (ONMD:NASDAQ) is .
SEC-8K** Filing Available For ONEMEDNET CORP (ONMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.